The targeting of gene transfer at the cell-entry level is one of the most attractive challenges in vector development. However. attempts to redirect adenovirus vectors to alternative receptors by engineering the capsid-coding region have shown limited success. because the proper targeting ligands on the cells of interest are generally unknown. https://olivebookmarks.com/story19598908/assessment-of-the-quality-of-the-healing-process-in-experimentally-induced-skin-lesions-treated-with-autologous-platelet-concentrate-associated-or-unassociated-with-allogeneic-mesenchymal-stem-cells-preliminary-results-in-a-large-animal-model